Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-003586
Filing Date
2022-04-29
Accepted
2022-04-29 21:02:08
Documents
2
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4212
2 POA 2021 jchildspoa21.txt EX-24 3256
  Complete submission text file 0001562180-22-003586.txt   8814
Mailing Address 111 HUNTINGTON AVENUE SUITE 2900 BOSTON MA 02199
Business Address
CHILDS JOHN W (Reporting) CIK: 0001027035 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 22878774

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations